Review of the molecular pathogenesis of the odontogenic keratocyst

Oral Oncology

Volumn 45, Issue 12, 2009, Pages 1011-1014

  Gomes, Carolina Cavaliéri ^a   Diniz, Marina Gonçalves ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Epigenetics; Genetics; Keratocystic odontogenic tumour; Odontogenic keratocyst; PTCH; Review

Indexed keywords

EPIGENETICS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; ODONTOGENIC KERATOCYST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EPIGENOMICS; GENES, P53; HUMANS; MANDIBULAR DISEASES; MICRORNAS; MUTATION; ODONTOGENIC CYSTS; RECEPTORS, CELL SURFACE;

EID: 70449532124     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.08.003     Document Type: Review

References (47)

1. Odell E.W., and Morgan P.R. Biopsy pathology of the oral tissues (1998), Chapman & Hall, London
2. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization classification of tumours. Pathology & genetics. Head and neck tumours (2005), IARC Press, Lyon
3. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol 38 (2002) 219-226
4. Li T.J., Browne R.M., and Matthews J.B. Quantification of PCNA positive cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 23 (1994) 184-189
5. Slootweg P.J. P53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 24 (1995) 393-397
6. Li T.-J., Browne R.M., and Matthews J.B. Epithelial cell proliferations in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med 24 (1995) 221-226
7. El Murtadi A.E., Grehan D., Toner M., and McCartan B.E. Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (1996) 217-220
8. Piattelli A., Fioroni M., Santinelli A., and Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 34 (1998) 408-412
9. Lo Muzio L., Staibano S., Pannone G., Bucci P., Nocini P.F., Bucci E., et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with nevoid basal cell carcinoma syndrome. J Dent Res 78 (1999) 1345-1353
10. Kimi K., Kumamoto H., Ooya K., and Motegi K. Immunohistochemical analysis of cell-cycle and apoptosis-related factor in lining epithelium of odontogenic keratocysts. J Oral Pathol Med 30 (2001) 434-442
11. Saraçoglu U., Kurt B., Günhan O., and Güven O. MIB-1 expression in odontogenic epithelial rests, epithelium of healthy oral mucosa and epithelium of selected odontogenic cysts. An immunohistochemical study. Int J Oral Maxillofac Surg 34 (2005) 432-435
12. Kolár Z., Geierová M., Bouchal J., Pazdera J., Zboril V., and Tyrdý P. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med 35 (2006) 75-80
13. Souza P.E.A., Mesquita R.A., and Gomez R.S. Evaluation of p53, PCNA, Ki-67, MDM-2 and AgNOR in oral peripheral and central giant cell lesions. Oral Diseases 6 (2000) 35-39
14. Kaplan I., Anavi Y., Manor R., Sulkes J., and Calderon S. The use of molecular markers as an aid in the diagnosis of glandular odontogenic cyst. Oral Oncol 41 (2005) 895-902
15. Agaram N.P., Collins B., Barnes L., Lomago D., Aldeeb D., Swalsky P., et al. Molecular analysis to demonstrate that odontogenic keratocyst are neoplastic. Arch Pathol Lab Med 128 (2004) 313-317
16. Henley J., Summerlin D.-J., Tomich C., Zhang S., and Cheng L. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histopathology 47 (2005) 582-586
17. Malcić A, Jukić S, Anić I, Pavelić B, Kapitanović S, Kruslin B, et al. Alterations of FHIT and P53 genes in keratocystic odontogenic tumour, dentigerous cyst and radicular cyst. J Oral Pathol Med 2008;37:294-301.
18. Partridge M., Costea D.E., and Huang X. The changing face of p53 in head and neck cancer. Int J Oral Maxillofac Surg 36 (2007) 1123-1138
19. Lombardi T., Odell E.W., and Morgan P.R. P53 immunohistochemistry of odontogenic keratocyst in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Archs Oral Biol 40 (1995) 1081-1084
20. Li T.J., Browne R.M., Prime S.S., Paterson I.C., and Matthews J.B. P53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 25 (1996) 249-255
21. Clark P., Marker P., Bastian H.L., and Krogdahl A. Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression. J Oral Pathol Med 35 (2006) 568-572
22. Heikinheimo K., Jee K.J., Morgan P.R., Nagy B., Knuutila S., and Leiva I. Genetic changes in sporadic keratocystic odontogenic tumors (Odontogenic Keratocysts). J Dent Res 86 (2007) 544-549
23. Lench N.J., Telford E.A., High A.S., Markham A.F., Wicking C., and Wainwright B.J. Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Hum Genet 100 (1997) 497-502
24. Barreto D.C., Gomez R.S., Bale A.E., Boson W.L., and De Marco L. PTCH gene mutations in odontogenic keratocysts. J Dent Res 79 (2000) 1418-1422
25. Ohki K., Kumamoto H., Ichinohasama R., Sato T., Takahashi N., Ooya K., et al. PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 33 (2004) 584-592
26. Gu X.M., Zhao H.S., Sun L.S., and Li T.J. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts. J Dent Res 85 (2006) 859-863
27. Sun L.S., Li X.F., and Li T.J. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res 87 (2008) 575-579
28. Hooper J.E., and Scott M.P. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6 (2005) 306-317
29. Pan S, Li T-J. PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation? Oral Oncol. doi:10.1016/j.oraloncology.2009.02.003.
30. Lindström E., Shimokawa T., Toftgård R., and Zaphiropoulos P.G. PTCH mutations: distribution and analyses. Hum Mutat 27 (2006) 215-219
31. Barreto D.C., Bale A.E., De Marco L., and Gomez R.S. Immunolocalization of PTCH protein in odontogenic cysts and tumors. J Dent Res 81 (2002) 757-760
32. Ayoubi T.A., and Van De Ven W.J. Regulation of gene expression by alternative promoters. FASEB J 10 (1996) 453-460
33. Kogerman P., Krause D., Rahnama F., Kogerman L., Undén A.B., Zaphiropoulos P.G., et al. Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene 21 (2002) 6007-6016
34. Shimokawa T., Rahnama F., and Zaphiropoulos P.G. A novel first exon of the Patched1 gene is upregulated by Hedgehog signaling resulting in a protein with pathway inhibitory functions. FEBS Lett 578 (2004) 157-162
35. Agren M., Kogerman P., Kleman M.I., Wessling M., and Toftgård R. Expression of the PTCH1 tumour suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene 330 (2004) 101-114
36. Nagao K., Toyoda M., Takeuchi-Inoue K., Fujii K., Yamada M., and Miyashita T. Identification and characterization of multiple isoforms of a murine and human tumour suppressor, patched, having distinct first exons. Genomics 85 (2005) 462-471
37. Shimokawa T., Svärd J., Heby-Henricson K., Teglund S., Toftgård R., and Zaphiropoulos P.G. Distinct roles of first exon variants of the tumour-suppressor Patched1 in Hedgehog signaling. Oncogene 26 (2007) 4889-4896
38. Diniz M.G., Borges E.R., Guimarães A.L.S., Moreira P.R., Brito J.A.R., Gomez M.V., et al. PTCH1 isoforms in odontogenic keratocysts. Oral Oncol 45 (2009) 291-295
39. Weber A., Wittekind C., and Tannapfel A. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of head and neck. Pathol Res Pract 199 (2003) 391-397
40. Robertson K.D., and Wolffe A.P. DNA methylation in health and disease. Nat Rev Genet 1 (2000) 11-19
41. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
42. Cretnik M., Musani V., Oreskovic S., Leovic D., and Levanat S. The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med 19 (2007) 875-883
43. Pritchard J.E., and Olson J.M. Methylation of PTCH1, the Patched 1 gene, in a panel of medulloblastoma. Cancer Genet Cytogenet 180 (2008) 47-50
44. Wolf I., Bose S., Desmond J.C., Lin B.T., Williamson E.A., Karlan B.Y., et al. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat 105 (2007) 139-155
45. Rocha P.R., Guimarães M.M., Guimarães A.L.S., Diniz M.G., Gomes C.C., Brito J.A.R., et al. Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med 38 (2009) 99-103
46. Chen C.Z. MicroRNAs as oncogenes and tumour suppressors. N Engl J Med 353 (2005) 1768-1771
47. Gomes C.C., and Gomez R.S. MicroRNA and oral cancer: future perspectives. Oral Oncol 44 (2008) 910-914